Benefits
Background: Lentinan Is a Separate Injectable Prescription Drug in Japan
This entry is regulatory and scientific background about a related pharmaceutical, not a benefit of eating shiitake. Purified lentinan has been a prescription drug in Japan since 1985, given by injection in hospital care alongside chemotherapy. The evidence behind it is an individual patient data meta-analysis of 5 randomized trials, n=650, in advanced or unresectable gastric cancer (overall survival hazard ratio 0.80, p=0.011), plus a review of 17 randomized trials, n=1,390, in non-small cell lung cancer in which lentinan was injected into the pleural cavity together with cisplatin; those review authors describe the included trials as low methodological quality with a high risk of bias. Oral lentinan is poorly absorbed, so the injected form drives that evidence. Eating shiitake or taking an oral shiitake supplement does not reproduce it, and shiitake is not a treatment for any disease.
Eritadenine and Cholesterol Metabolism (Laboratory and Animal Data)
Shiitake contains eritadenine, a compound studied for its effect on phospholipid metabolism and the S-adenosyl methionine cycle. The evidence cited here is laboratory work in Caco-2 and HepG2 cell monolayers plus mice, and those authors state that further dose-dependent studies should be carried out. The roughly 25 percent LDL reduction that is sometimes quoted comes from animal feeding studies. No human cholesterol outcome was measured in any study cited on this page.
Immune Modulation
Beta-glucans act on innate immune pathways, including NK cells, macrophages, and dendritic cells. The human evidence here is a single randomized dietary intervention: 52 healthy adults aged 21 to 41 ate 5 or 10 g/day of whole dried shiitake as food for 4 weeks. Gamma-delta T-cell proliferation rose about 60 percent (p<0.0001), NK-T cells roughly doubled (p<0.0001), secretory IgA increased and C-reactive protein fell. Those are immune markers measured in blood, not rates of illness. No study cited on this page measured respiratory infections or infection severity.
Antioxidant Activity
Polyphenols, ergothioneine (a sulfur-containing amino acid), and other compounds contribute to antioxidant capacity measured in the laboratory. No study cited on this page measured an antioxidant outcome in people. Ergothioneine particularly notable as essentially mushroom-exclusive antioxidant.
Vitamin D Source (UV-Exposed)
Shiitake (and other mushrooms) contain ergosterol that converts to ergocalciferol (vitamin D2) when exposed to UV light. UV-treated shiitake (commercially available) provides meaningful vitamin D2 — among few non-animal vitamin D sources.
Mechanism of action
Lentinan Immune Activation
Lentinan is a 1,3-beta-glucan that activates dectin-1 and complement receptor pathways on immune cells. Activates Th1 cellular immunity and NK cell function in laboratory models. This mechanistic work used purified lentinan, the isolated compound that is given by injection as a prescription medicine in Japan, rather than shiitake as eaten.
Eritadenine Cholesterol Mechanism
Eritadenine (2(R),3(R)-dihydroxy-4-(9-adenyl)-butyric acid) has been shown in cell and animal models to interfere with hepatic phospholipid biosynthesis and to alter lipoprotein metabolism. This is a proposed mechanism only. It has not been shown to change cholesterol in any human study cited here, and shiitake is not a substitute for a prescribed cholesterol medicine.
Ergothioneine Antioxidant
Ergothioneine is a sulfur-containing amino acid found almost exclusively in mushrooms (and bacteria/fungi). Acts as cellular antioxidant; concentrated in tissues with high oxidative stress (kidney, liver, RBCs).
UV Conversion to Vitamin D2
Ergosterol in mushrooms converts to ergocalciferol (D2) when exposed to UV light. UV-exposed shiitake can provide significant D2 (manufacturers sun-dry or UV-treat for this purpose).
Clinical trials
Individual patient data meta-analysis of 5 randomized controlled trials, n=650, of lentinan given by injection as an adjunct to chemotherapy in advanced or unresectable gastric cancer (Oba 2009).
Adults with advanced, unresectable or recurrent gastric cancer receiving chemotherapy in hospital.
Overall survival hazard ratio 0.80 (p=0.011) when injected lentinan was added to chemotherapy. Approved by Japanese authorities as prescription adjunct cancer drug since 1985. Critical: injectable formulation; oral lentinan has limited absorption. This describes a hospital drug given by injection and is not evidence for what eating shiitake or taking an oral shiitake extract does.
Randomized dietary intervention, n=52 healthy adults aged 21 to 41, eating whole dried shiitake as food at 5 g or 10 g/day for 4 weeks. Outcomes: immune cell function, inflammation markers.
Healthy adults.
Gamma-delta T-cell proliferation increased about 60 percent (p<0.0001) and NK-T cells roughly doubled (p<0.0001); secretory IgA increased and C-reactive protein decreased. This is human, food-based evidence for a general immune-supportive role of dietary shiitake, though these are immune markers measured in blood rather than rates of infection or illness.